Streetbeat News

Assets

CHRS

NVS

Coherus BioSciences, Inc. (NASDAQ:CHRS) has agreed to sell its CIMERLI ophthalmology franchise to Sandoz, a unit of Novartis (NYSE:NVS), for $170 million in cash. The deal includes the CIMERLI biologics license application, sales and reimbursement teams, product inventory, and commercial software.

Portfolio Pulse from Charles Gross

January 22, 2024 | 10:29 am

AAPL

FXI

XIACF

The China Academy of Information and Communications Technology reported that smartphone shipments within China were nearly flat year-over-year at 26.84 million units in December. However, for the full year of 2023, shipments were up 4.8% at 276 million units.

Portfolio Pulse from Charles Gross

January 22, 2024 | 9:53 am

EVTL

Vertical Aerospace (NYSE:EVTL) has received a $50 million investment commitment from its founder, CEO, and majority owner Stephen Fitzpatrick. This funding extends the company's cash runway into Q2 2025 and will support the development of the certification aircraft design, which is set to undergo prototype testing this year followed by final regulatory testing before production.

Portfolio Pulse from Benzinga Newsdesk

January 22, 2024 | 9:46 am

BTCUSD

The pool of U.S. presidential candidates supportive of cryptocurrency has diminished with the withdrawal of Vivek Ramaswamy and Ron DeSantis from the race. This leaves Dean Phillips and Robert F. Kennedy Jr. as the remaining pro-crypto candidates. Donald Trump, who has previously criticized cryptocurrencies, has recently opposed central bank digital currencies (CBDCs) and launched a series of NFTs with Bitcoin Ordinals. Bitcoin's price is currently at $41,133, down 1.12%.

Portfolio Pulse from Mehab Qureshi

January 22, 2024 | 7:10 am

CHRS

Coherus BioSciences, Inc. (NASDAQ:CHRS) has agreed to sell its CIMERLI ophthalmology franchise to Sandoz for $170 million in cash, plus additional amounts for product inventory and working capital adjustments. The deal includes the CIMERLI biologics license application, sales and reimbursement teams, product inventory, and commercial software.

Portfolio Pulse from Benzinga Newsdesk

January 22, 2024 | 6:44 am

BTCUSD

DOGEUSD

Dogecoin (DOGE) experienced a significant rally over the weekend, with its price jumping over 10% from $0.078 to $0.090, driven by excitement over a new 'X payments' system. However, the rally has since paused, with DOGE's price dropping by 4% to $0.083. The downturn coincided with $2.65 million worth of Dogecoin long positions being liquidated. The market cap of Dogecoin has risen to approximately $11.8 billion. Speculation is growing that the tech billionaire behind the 'X payments' system may enter the blockchain payment services sector, which could be related to Elon Musk's known support for Dogecoin.

Portfolio Pulse from Mehab Qureshi

January 22, 2024 | 5:25 am

BTCUSD

DOGEUSD

ETHUSD

Major cryptocurrencies Bitcoin, Ethereum, and Dogecoin saw declines as Google search interest for 'Bitcoin ETF' dropped significantly. Bitcoin ETF interest peaked on January 10 but fell to less than 8 by January 22. The global cryptocurrency market cap decreased by 3.45% to $1.62 trillion. Stock futures were stable, with minimal movement on Sunday evening. Analysts predict a consolidative period for cryptocurrencies, with potential for the total market cap to push towards $2.1 trillion through altcoins. Bitcoin may drop below $40,000 before the April halving, but recent bullish signals suggest a possible rebound.

Portfolio Pulse from Mehab Qureshi

January 22, 2024 | 3:00 am

BTSG

CGON

HWEP

BrightSpring Health Services, Inc (BTSG), CG Oncology, Inc. (CGON), and HW Electro Co., Ltd (HWEP) are set to go public this week with their IPOs. BTSG is offering shares at $16.50 within a $15.00-$18.00 range, CGON at $17.00 within a $16.00-$18.00 range, and HWEP at $4.00 per share. All three have a 180-day lockup period.

Portfolio Pulse from Benzinga Insights

January 21, 2024 | 7:37 pm

BTCUSD

Vanguard faces criticism from cryptocurrency investors for not offering spot Bitcoin ETFs despite SEC approval. Investor Mike Alfred and CoinRoutes co-CEO Dave Weisberger publicly expressed their dissatisfaction, with Alfred moving his accounts and Weisberger calling it a catastrophic marketing move. Some clients have reportedly shifted their accounts to Fidelity in response to Vanguard's conservative stance towards crypto.

Portfolio Pulse from Bibhu Pattnaik

January 21, 2024 | 5:28 pm

GBTC

Gary Black, Managing Partner at Future Fund, predicts a potential 70% plunge in Bitcoin's value following a lackluster response to the launch of 11 new spot Bitcoin ETFs. Despite approval, these ETFs saw modest inflows, contrasting with the outflows from the Grayscale Bitcoin Trust (GBTC), which has higher fees. Black references a historical drop in Bitcoin's price post-2020-2021 gains as a basis for his prediction. Meanwhile, Bitcoin bulls like Cathie Wood remain optimistic, with Wood predicting a value of $1.5 million by 2030. Bitcoin was slightly up at $41,855.37 at the time of reporting.

Portfolio Pulse from Shanthi Rexaline

January 21, 2024 | 3:46 pm